PTI
Proteostasis Therapeutics, Inc.
Cormorant Asset Management, LLC bought $1.7M of Proteostasis Therapeutics, Inc.
10% owner
Bought$1,744,116
$10.24Price
170,391Shares
+5%Stake
What PTI did for a copier
Prices for PTI after this filing aren't in yet.
Cormorant Asset Management, LLC's record
17 other buys with 3 months of prices since 2016: on average −6.0% against the S&P 500, and 8 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 29. Filed Thu, Dec 1, 11:59 AM ET, during the session. Not investment advice.